Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
The Future of RET Inhibitors in Non-Small Cell Lung and Thyroid Cancer
EP. 1: Why RET Alteration is an Attractive Target for Therapy
October 18th 2019
EP. 2: RET Fusion, Point Mutation, and Signaling
October 18th 2019
EP. 3: Multikinase TKIs for NSCLC and Medullary Thyroid Cancer
October 18th 2019
EP. 4: RET Treatment: Novel Compounds to Replace Current TKIs
October 18th 2019
EP. 5: The Importance of NGS Testing
October 18th 2019
EP. 6: RET Testing in Papillary and Medullary Thyroid Cancer
October 18th 2019
EP. 7: LIBRETTO-001 Regimen Overview
October 18th 2019
EP. 8: LOXO-292 in Patients With RET-Fusion Lung Cancer
October 18th 2019
EP. 9: ESMO 2019 LIBRETTO-001 Trial Updates
October 18th 2019
EP. 10: How BLU-667 Has Changed the Treatment Landscape
October 18th 2019
NEXT PAGE
<
1
2
>
PREVIOUS PAGE